Carregant...
NF-κB Inhibition Suppresses Experimental Melanoma Lung Metastasis
BACKGROUND: Although novel therapeutic regimens for melanoma continue to emerge, the best current clinical response rate is still less than 60%. Moreover, antimelanoma treatments contribute to toxicities in other vital organs. In this study, we elucidate the therapeutic advantages of siRNA targeting...
Guardat en:
| Publicat a: | J Cancer Sci Clin Ther |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497821/ https://ncbi.nlm.nih.gov/pubmed/32954352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.26502/jcsct.5079070 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|